Jazz Pharmaceuticals Denmark ApS: Financial statements 2020
CVR: 39791447
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Jazz Pharmaceuticals Denmark ApS (CVR 39791447) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 16,469,482 and a net result of DKK 1,540,505. Equity in the 2020 report amounted to DKK 7,628,522. The solvency ratio was 39.6%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 16,469,482
- Profit/Loss
- DKK 1,540,505
- Equity
- DKK 7,628,522
- Total Assets
- DKK 19,286,019
- Employees
- 14
Official annual report
How creditworthy is Jazz Pharmaceuticals Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Jazz Pharmaceuticals Denmark ApS has published its interim report for the period August 17, 2018 – December 31, 2019.
About Jazz Pharmaceuticals Denmark ApS
Jazz Pharmaceuticals Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of David James Spackman and Kamilla Enggaard Have. The company is owned by Jazz Pharmaceuticals Ireland Holdings Limited. The company has 13 employees (2026). In 2025, the company reported a gross profit of DKK 41,044,332 and a net result of DKK 1,528,396 compared with DKK 1,538,214 the year before. Equity in the 2025 report amounted to DKK 13,823,507.